Recommended management of lower respiratory tract infections
Identifieur interne : 003289 ( Main/Curation ); précédent : 003288; suivant : 003290Recommended management of lower respiratory tract infections
Auteurs : Sarah MeisnerSource :
- Prescriber [ 0959-6682 ] ; 2008-09-19.
English descriptors
- Teeft :
- Acute bronchitis, Acute exacerbation, Acute exacerbations, Aetiology, Aggressive strains, Amoxicillin, Antibiotic, Antibiotic therapy, Antimicrobial resistance, Atypical, Atypical organisms, Atypical pathogens, British thoracic society, British thoracic society guidelines, Broad spectrum, Bronchitis, Causative agents, Chronic bronchitis, Chronic disease, Chronic pneumonia, Churchill livingstone, Clinical knowledge summaries, Common infection, Copd, Core features, Cystic fibrosis, Empirical therapy, Erythromycin, Exacerbation, Fluoroquinolones, Funds research, Green book, Guideline, Health protection agency, Immunisation, Infectious diseases, Influenza, Influenza virus, Influenzae, Initial assessment, Intravenous therapy, Legionella species, Lrtis, Lung abscesses, Lung function, Macrolides, Mycoplasma, Newer fluoroquinolones, Newer macrolides, Other causes, Other viruses, Pathogen, Penicillin resistance, Pertussis, Pneumococcus, Pneumonia, Pneumoniae, Pregnant women, Prescriber, Preventive measures, Primary care, Pulmonary disease, Respiratory tract infections, Risk factors, September, Social circumstances, Sputum, Sputum production, Strep, Tetracycline, Tract infection, Tract infections, Viral, Wide range, Young children.
Abstract
Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd
Url:
DOI: 10.1002/psb.285
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001041
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001041
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000F63
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003391
Links to Exploration step
ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recommended management of lower respiratory tract infections</title><author><name sortKey="Meisner, Sarah" sort="Meisner, Sarah" uniqKey="Meisner S" first="Sarah" last="Meisner">Sarah Meisner</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/psb.285</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-3MMNJFHC-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001041</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001041</idno><idno type="wicri:Area/Istex/Curation">001041</idno><idno type="wicri:Area/Istex/Checkpoint">000F63</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F63</idno><idno type="wicri:doubleKey">0959-6682:2008:Meisner S:recommended:management:of</idno><idno type="wicri:Area/Main/Merge">003391</idno><idno type="wicri:Area/Main/Curation">003289</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Recommended management of lower respiratory tract infections</title><author><name sortKey="Meisner, Sarah" sort="Meisner, Sarah" uniqKey="Meisner S" first="Sarah" last="Meisner">Sarah Meisner</name></author></analytic><monogr></monogr><series><title level="j" type="main">Prescriber</title><title level="j" type="alt">PRESCRIBER</title><idno type="ISSN">0959-6682</idno><idno type="eISSN">1931-2253</idno><imprint><biblScope unit="vol">19</biblScope><biblScope unit="issue">18</biblScope><biblScope unit="page" from="21">21</biblScope><biblScope unit="page" to="40">40</biblScope><biblScope unit="page-count">12</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2008-09-19">2008-09-19</date></imprint><idno type="ISSN">0959-6682</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-6682</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute bronchitis</term><term>Acute exacerbation</term><term>Acute exacerbations</term><term>Aetiology</term><term>Aggressive strains</term><term>Amoxicillin</term><term>Antibiotic</term><term>Antibiotic therapy</term><term>Antimicrobial resistance</term><term>Atypical</term><term>Atypical organisms</term><term>Atypical pathogens</term><term>British thoracic society</term><term>British thoracic society guidelines</term><term>Broad spectrum</term><term>Bronchitis</term><term>Causative agents</term><term>Chronic bronchitis</term><term>Chronic disease</term><term>Chronic pneumonia</term><term>Churchill livingstone</term><term>Clinical knowledge summaries</term><term>Common infection</term><term>Copd</term><term>Core features</term><term>Cystic fibrosis</term><term>Empirical therapy</term><term>Erythromycin</term><term>Exacerbation</term><term>Fluoroquinolones</term><term>Funds research</term><term>Green book</term><term>Guideline</term><term>Health protection agency</term><term>Immunisation</term><term>Infectious diseases</term><term>Influenza</term><term>Influenza virus</term><term>Influenzae</term><term>Initial assessment</term><term>Intravenous therapy</term><term>Legionella species</term><term>Lrtis</term><term>Lung abscesses</term><term>Lung function</term><term>Macrolides</term><term>Mycoplasma</term><term>Newer fluoroquinolones</term><term>Newer macrolides</term><term>Other causes</term><term>Other viruses</term><term>Pathogen</term><term>Penicillin resistance</term><term>Pertussis</term><term>Pneumococcus</term><term>Pneumonia</term><term>Pneumoniae</term><term>Pregnant women</term><term>Prescriber</term><term>Preventive measures</term><term>Primary care</term><term>Pulmonary disease</term><term>Respiratory tract infections</term><term>Risk factors</term><term>September</term><term>Social circumstances</term><term>Sputum</term><term>Sputum production</term><term>Strep</term><term>Tetracycline</term><term>Tract infection</term><term>Tract infections</term><term>Viral</term><term>Wide range</term><term>Young children</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lower respiratory tract infections comprise a wide range of pathologies and causative pathogens that require differentiating in order to administer the most appropriate treatment. Our Drug review discusses the current recommended management of LRTIs in the community, followed by sources of further information in Resources. Copyright © 2008 Wiley Interface Ltd</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003289 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003289 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:36F2A574BBAF64B47C5D0D45BE266B0C9EB8A0D9
|texte= Recommended management of lower respiratory tract infections
}}
| This area was generated with Dilib version V0.6.33. |  |